Composition and method for increasing apoptosis in cancer cells
AssigneeCeltek Bioscience, LLC
InventorsYao-Zhong Lin, Claudia Budu
Life of this patent
Estimating the term…
Loading patent…
AssigneeCeltek Bioscience, LLC
InventorsYao-Zhong Lin, Claudia Budu
Estimating the term…
The invention provides cell permeable peptides and peptide agents that inhibit anti-apoptotic processes in cancer cells to promote tumor cell death, as well as a method for providing therapeutic treatment for cancer. The composition may be delivered in conjunction with a conventional chemotherapeutic agent to provide a synergistic effect that significantly increases the effectiveness of the chemotherapeutic agent to destroy cancer cells. The invention also provides kits or systems for cancer therapy, comprising at least one peptide agent for inhibiting the anti-apoptotic effects of NF-kB and at least one chemotherapeutic agent for stimulating the cellular apoptotic pathway.
An isolated polypeptide comprising a cell-permeable peptide of about 11 to about 50 residues comprising SEQ ID NO:
An isolated cell permeable peptide of about 11 to about 50 amino acids comprising SEQ ID NO:
Dependencies are inferred from the claim text.